Skip to main content

Table 4 Baseline characteristics of shunt procedures: Cohorts' comparison

From: Protective effect of rifampicin and clindamycin impregnated devices against Staphylococcusspp. infection after cerebrospinal fluid diversion procedures

 

No. PROCEDURES (%) (n = 119)

 

VARIABLES

TREATMENT COHORT (n = 72)

CONTROL COHORT (n = 47)

pvalue

Age:

  

0.027

6 months

6 (8.3)

8 (17.0)

NS

7 months-14 years

7 (9.7)

12 (25.5)

0.021

15-69 years

40 (55.6)

16 (34.0)

0.022

70 years

19 (26.4)

11 (23.4)

NS

Sex Male

38 (52.7)

30 (63.8)

0.234

CSF infection in previous 6 months

16 (22.2)

10 (21.3)

0.903

Previous shunt

16 (22.2)

19 (40.4)

0.033

Diagnosis:

  

0.071

Traumatic brain injury

4 (5.6)

0 (0)

NS

Vascular disease

6 (8.3)

3 (6.4)

NS

CVA +/- IVH

1 (1.4)

0 (0)

NS

Tumour

21 (29.2)

6 (12.8)

NS

Premature IVH

6 (8.3)

5 (10.6)

NS

Normal-pressure hydrocephalus

17 (23.6)

16 (34.0)

NS

Others

17 (23.6)

17 (36.1)

NS

Type of surgery:

  

0.001

De novo

55 (76.4)

27 (57.4)

0.029

Proximal revision

6 (8.3)

2 (4.3)

NS

Distal revision

4 (5.5)

0 (0)

NS

Full revision

7 (9.7)

18 (38.3)

<0.001

Follow-up, median (IQR), days

384.5 (184-704.75)

385 (144-1085)

0.910

  1. n: sample size; CSF: cerebrospinal fluid; CVA: cerebrovascular accident; IVH: intraventricular haemorrhage; IQR: interquartilic range; NS: non significant